TY - JOUR
T1 - Advancing Therapeutic Protein Discovery and Development through Comprehensive Computational and Biophysical Characterization
AU - Gentiluomo, Lorenzo
AU - Svilenov, Hristo L
AU - Augustijn, Dillen
AU - El Bialy, Inas
AU - Greco, Maria Laura
AU - Vitaliyivna Kulakova, Alina
AU - Indrakumar, Sowmya
AU - Mahapatra, Sujata
AU - Morales, Marcello Martinez
AU - Pohl, Christin
AU - Roche, Aisling
AU - Tosstorff, Andreas
AU - Curtis, Robin
AU - Derrick, Jeremy P
AU - Nørgaard, Allan
AU - Khan, Tarik A
AU - Peters, Günther H.J.
AU - Pluen, Alain
AU - Rinnan, Åsmund
AU - Streicher, Werner W
AU - van der Walle, Christopher F
AU - Uddin, Shahid
AU - Winter, Gerhard
AU - Roessner, Dierk
AU - Harris, Pernille
AU - Frieß, Wolfgang
PY - 2020
Y1 - 2020
N2 - Therapeutic protein candidates should exhibit favorable properties that render them suitable to become drugs. Nevertheless, there are no well-established guidelines for the efficient selection of proteinaceous molecules with desired features during early stage development. Such guidelines can emerge only from a large body of published research that employs orthogonal techniques to characterize therapeutic proteins in different formulations. In this work, we share a study on a diverse group of proteins, including their primary sequences, purity data, and computational and biophysical characterization at different pH and ionic strength. We report weak linear correlations between many of the biophysical parameters. We suggest that a stability comparison of diverse therapeutic protein candidates should be based on a computational and biophysical characterization in multiple formulation conditions, as the latter can largely determine whether a protein is above or below a certain stability threshold. We use the presented data set to calculate several stability risk scores obtained with an increasing level of analytical effort and show how they correlate with protein aggregation during storage. Our work highlights the importance of developing combined risk scores that can be used for early stage developability assessment. We suggest that such scores can have high prediction accuracy only when they are based on protein stability characterization in different solution conditions.
AB - Therapeutic protein candidates should exhibit favorable properties that render them suitable to become drugs. Nevertheless, there are no well-established guidelines for the efficient selection of proteinaceous molecules with desired features during early stage development. Such guidelines can emerge only from a large body of published research that employs orthogonal techniques to characterize therapeutic proteins in different formulations. In this work, we share a study on a diverse group of proteins, including their primary sequences, purity data, and computational and biophysical characterization at different pH and ionic strength. We report weak linear correlations between many of the biophysical parameters. We suggest that a stability comparison of diverse therapeutic protein candidates should be based on a computational and biophysical characterization in multiple formulation conditions, as the latter can largely determine whether a protein is above or below a certain stability threshold. We use the presented data set to calculate several stability risk scores obtained with an increasing level of analytical effort and show how they correlate with protein aggregation during storage. Our work highlights the importance of developing combined risk scores that can be used for early stage developability assessment. We suggest that such scores can have high prediction accuracy only when they are based on protein stability characterization in different solution conditions.
U2 - 10.1021/acs.molpharmaceut.9b00852
DO - 10.1021/acs.molpharmaceut.9b00852
M3 - Journal article
C2 - 31790599
SN - 1543-8384
VL - 17
SP - 426
EP - 440
JO - Molecular Pharmaceutics
JF - Molecular Pharmaceutics
IS - 2
ER -